Physician

Pamela R Gardner, DO

According to 2025 Medicare claims, Pamela Gardner, DO (NPI: 1457315004) practices cardiology in the Lima, OH market, with the plurality of this provider's patient population coming from Allen, OH. This provider's primary affiliated billing organization is LIMA MEMORIAL PROFESSIONAL CORPORATION (NPI: 1457474900; TIN: 341935236) and primary practice location at 45804-2800.

Gardner's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,559 traditional Medicare patients, billed 4,995 HCPCS/CPT codes, and received $169,612 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 14,850 prescription claims across 1,463 beneficiaries totaling $1,860,758 in drug costs, led by Eliquis (Apixaban). DME data shows 28 claims. Open Payments data shows 73 records totaling $2,260. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $500,932 to $1,860,758. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $39,664 to $4,829.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,102	6,221	$230,241
2016	2,229	6,329	$249,919
2017	2,015	5,740	$246,234
2018	1,998	5,398	$221,010
2019	1,990	5,498	$207,604
2020	1,709	5,293	$203,600
2021	1,771	5,929	$246,220
2022	1,790	5,635	$210,742
2023	1,582	4,965	$187,831
2024	1,559	4,995	$169,612

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	834	9,132	$500,932
2016	864	9,782	$608,388
2017	952	9,968	$757,080
2018	1,101	11,083	$1,037,961
2019	1,129	11,982	$1,345,900
2020	1,162	12,540	$1,467,942
2021	1,375	13,757	$1,686,396
2022	1,391	13,971	$1,775,997
2023	1,332	13,665	$1,869,073
2024	1,463	14,850	$1,860,758

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	126	$35,322
2016	N/R	67	$4,545
2017	N/R	43	$1,738
2018	N/R	33	$2,066
2019	N/R	49	$3,798
2020	N/R	53	$4,261
2021	N/R	58	$4,329
2022	N/R	49	$4,858
2023	N/R	81	$7,712
2024	N/R	28	$3,389

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	561	783	$61
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	289	292	$47
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	415	518	$42
93016	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician	270	273	$15
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	871	1,290	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	662	45,538	$857,173
Repatha Sureclick	Evolocumab	115	9,128	$175,399
Entresto	Sacubitril/Valsartan	122	6,738	$142,963
Farxiga	Dapagliflozin Propanediol	114	7,617	$139,839
Xarelto	Rivaroxaban	82	5,204	$92,912

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	28	$3,389

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	73	$2,260	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Pamela R. Gardner, DO?

Tedicare shows public-source Medicare data for Pamela R. Gardner, DO (NPI 1457315004), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Pamela R. Gardner, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Pamela R. Gardner, DO?

Pamela R. Gardner, DO is linked to LIMA MEMORIAL PROFESSIONAL CORPORATION (billing NPI 1457474900) in the available physician profile data.

Does Pamela R. Gardner, DO have Open Payments data?

Pamela R. Gardner, DO has 73 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.